Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial

Lu, Charles; Jack Lee, J.; Komaki, Ritsuko; S. Herbst, Roy; Feng, Lei; K. Evans, William; Choy, Hak; Desjardins, Pierre; Esparaz, Benjamin; T. Truong, Mylene; Saxman, Scott; Kelaghan, Joseph; Bleyer, Archie; Fisch, Michael

doi:10.1093/jnci/djq179

Public

Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial

Published in JNCI Journal of the National Cancer Institute • May 27, 2010

Authors:

Charles Lu

J. Jack Lee

Ritsuko Komaki

Abstract

BACKGROUND AE-941 is a standardized aqueous shark cartilage extract with antiangiogenic properties that has previously been evaluated in phase I and II clinical trials. Our objective was to determine the effect of adding AE-941 to chemoradiotherapy on overall survival of patients with unresectable s...

Subject

Lung cancer

Chemoradiotherapy

Stage (stratigraphy)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!